The Children’s Tumor Foundation is now offering Clinical Trial Awards up to $125,000 to fund pilot-scale clinical testing of potential candidate drugs for the treatment of tumors and other manifestations of NF1, NF2 or schwannomatosis. Two CTF-funded neurofibromatosis trials are currently underway and recruiting patients: a Phase Zero trial of lapatinib for treatment of NF2 vestibular aschwannomas (Dr. Jaishri Blakeley, Johns Hopkins University) and a Phase I trial of sorafenib for treatment of plexiform neurofibromas (Dr. Bruce Korf, University of Alabama at Birmingham). Interested applicants must submit a Letter of Intent (brief outline) first; applications accepted on a rolling basis. More information: click here.
Foundation Grants Available to Fund Small Neurofibromatosis Clinical Trials
